Back to results
US 2010/0249206 A1Published application
Modified lysine-mimetic compounds
AssigneeZealand Pharma A/S and Wyeth
InventorsBjarne Due Larsen, Jorgen Soberg Petersen, Ketil Jorgen Haugan, John A. Butera, James K. Hennan, Edward H. Kerns, Evgueni Lvovich Piatnitski
Life of this patent
Estimating the term…
Abstract
Lysine mimetic compounds having useful pharmacological activity such as antiarrhythmic activity and desirable bioavailability properties are disclosed.
Claims13
1-96. (canceled)
A method of treating or preventing a pathological condition comprising administering to a subject a therapeutically effective amount of a compound that is
- or a pharmaceutically acceptable salt thereof.
A method of treating or preventing a pathological condition comprising administering to a subject a therapeutically effective amount of a compound that is
- or a pharmaceutically acceptable salt thereof.
Dependencies are inferred from the claim text.